Liminatus Pharma, Inc. Share Price & Technical Analysis

LIMN · $0.17 (-32.00%)

Healthcare / Biotechnology

AI Score 24 · Bearish

$0.17

-32.00%

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Price chart

Seasonality

May has 0 positive and 1 negative years (last 2 years shown)

0% return in May, -41% avg return in past 3 year May month.

-50% return in 2026, -169% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
260%-50%0%0%0%-50%
25-41%109%-47%-56%-43%-18%-29%-45%-169%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 24/100

Bearish · Downtrend · Oversold

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$8.91M

P/E ratio

52W high

$33.66

52W low

$0.13

Volume

2,49,30,506

Beta

0.76

Related stocks in Healthcare

Frequently asked questions

What is Liminatus Pharma, Inc. share price today?
Liminatus Pharma, Inc. (LIMN) last traded around $0.17 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does LIMN have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LIMN. Download the app for real-time alerts.
How can I analyze Liminatus Pharma, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro